Inspira™ Receives CSA Certification of Compliance to U.S. Standards for the INSPIRA™ ART100
#Customers
Inspira™ Signs Term Sheet for Use of INSPIRA™ ART100 Device in Organ Transplant Procedures
#Partners
Inspira™ and Ennocure In Vitro Study Results Show 100% Prevention of Bacterial Growth that Causes Bloodstream Infections
#Partners, Research and Development
Inspira™ Announces Program to Pioneer the Applicable Use of the INSPIRA™ ART100 Device for an Artificial Womb
#Customers #Expand
Inspira™ Announces $1.65 Million Registered Direct Offering of Ordinary Shares by Inspira CEO's Mother with Leading Fund Manager
#Investment
Companies Like Inspira Technologies Oxy B.H.N (NASDAQ:IINN) Could Be Quite Risky
#Investment
Inspira™ Technologies Reports Full Year 2023 Financial Results
#Customers #Partners #Management Changes
Inspira Technologies (IINN) Strives to Get AMAR Nod for ART100
#Customers #Expand
Inspira™ Announces AMAR Regulatory Submission of the INSPIRA™ ART100, to Enter the Southeast Asia and South American Markets
#Customers #Expand
Inspira Technologies (IINN) Releases Favorable Data on VORTX
#Customers #Investment
Inspira™ Releases New Data Demonstrating Superiority of its Core Technology, Across Key Endpoints of HMSS Indicator
#Investment
Inspira™ Announces Plans to Report the Primary Results for a Core Blood Oxygenation Technology Within Days
#Investment #Expand
Inspira™ Announces Breakthrough Update: Nears First FDA 510(k) Approval, 3 U.S. Patents Approved, $546 million in Summary Distribution Agreements
#Customers #Partners #Investment
Inspira™ To Host Conference Call to Discuss Investor Presentation and Announce Next Major Milestone
undefined
Inspira™ introduces high-end platform for bio-mimicking blood parameters for development and testing of core technologies
#Investment, Expand
15 Hot Penny Stocks On the Move
#Investment
Inspira™ Receives First Ever U.S. Patent Approval for an Orbiting Blood Oxygenation Delivery System
#Customers #Investment
Inspira™ Technologies Collaborates with a Leading Israeli Medical Center for Clinical Evaluation of INSPIRA™ ART Device
#Partners
Inspira™ Technologies Signs Strategic Agreement to Enter Gulf States with Glo-Med for Deployment of 531 INSPIRA™ ART Devices
#Partners #Expand
Inspira™ Announces Plans to Launch and Target Single-Use Disposable Blood Oxygenation Kit for a New Disposable Perfusion Market Opportunity
#Customers #Expand
Inspira™ Technologies Signs Letter of Intent with Northwestern Memorial Hospital in Chicago for Clinical Use of INSPIRA™ ART100 Device
#Partners #Expand
Inspira™ Technologies Closes on $3.88 Million Registered Direct Offering
#Investment
Inspira™ Announces 95% Accuracy Results for HYLA™ Blood Sensor, Planning FDA Submission for Clearance in 2024
#Customers #Partners
Inspira Announces $3.88 Million Registered Direct Offering
#Investment
Inspira Technologies to Participate in J.P. Morgan Healthcare Conference
#Management Changes #Expand
In Preparation for FDA Clearance and Device Deployment, Inspira has Appointed Dr. Dan Gorfil, to Medical Advisory Board
#Management Changes
Inspira (IINN) Expands in Life Support Space With New Deal
#Partners
Inspira Collaborates with Ennocure for development of a Proprietary Bio-Electronic Treatment to Prevent Associated Bloodstream Infections in ICU Patients
#Partners #Expand
Inspira™ Technologies Reports Third Quarter 2023 Financial Results
#Investment #Expand
Inspira™ Announces Israeli Innovation Authority Grant for New VORTX™ Disposable Blood Oxygenation Technology
#Investment
Inspira™ Granted U.S. Patent for INSPIRA™ ART500 Medical Device
#Investment
Inspira™ Terminates ATM Program and Provides an Update
#Customers #Partners
Inspira™ Enters into a Distribution Agreement in Central America with CIO MED GROUP
undefined
Inspira™ Technologies Unveils the INSPIRA™ ART Line of Medical Devices at the World's Largest Extracorporeal Life Support Conference
undefined
Inspira™ Announces 510(k) FDA Submission of INSPIRA™ ART100 Towards Commercialization
#Investment #Expand
Inspira (IINN) Advances Foothold in Europe With Extended Deal
#Partners #Customers
Inspira™ Signs Agreement Expansion with Innovimed for Clinical Trials of INSPIRA™ ART Respiratory Medical Devices
#Partners
Inspira™ Technologies Reports Second Quarter 2023 Financial Results
undefined
INSPIRA™ ART100 Completes Usability Study in Boston Massachusetts, U.S.
undefined
Inspira™ Technologies Receives Certification of Medical Devices Quality Management Systems, Another Step Towards EU Regulatory Approval
undefined
Inspira™ Technologies Enters into Collaboration Agreement with U.S.-Based Perfusion Solution Inc.
undefined
Inspira™ Technologies Unveils Investor Deck Showcasing Revolutionary Advancement in Acute Respiratory Care
#Investment #Partners
Inspira Technologies Appoints Dr. Nir as Chief Medical Officer
#Management Changes
Inspira™ Technologies Reports First Quarter 2023 Financial Results
#Investment #Expand
Inspira™ Technologies will Reveal the New ALICE™ Device at the World's Largest Extracorporeal Life Support Conference
#Partners #Investment
Inspira™ Technologies is Developing the VORTX™ Blood Oxygenator, a Unique Technology for Saturating Blood With Oxygen and Removing Carbon Dioxide
#Customers #Investment
Inspira Technologies and Genius Group Interviews to Air on Bloomberg TV on the RedChip Money Report(R)
undefined
Keynotes, Educational Panels and 77 Companies to Present at the Planet MicroCap Showcase: VEGAS on April 25-27, 2023 at the Horseshoe Hotel & Casino in Las Vegas, NV
undefined
Inspira(TM) Technologies to Present at the Planet MicroCap Showcase 2023 on Wednesday, April 26, 2023 in Las Vegas
#Partners
Inspira™ Technologies Reports Fourth Quarter 2022 and Full Year Financial Results
undefined
Inspira™ Technologies Announces First in Human of HYLA™ Blood Sensor in Clinical Study
#Customers
Inspira™ Technologies Receives Approval from Sheba Medical Center to Conduct Clinical Study of the HYLA™ Blood Sensor
#Customers
Inspira™ Technologies Granted Patent by U.S. Patent Office for the INSPIRA™ ART System's Convertible Dual Lumen Cannula Device and Method of Use
undefined
Diamond Equity Research Initiates Coverage on Inspira Technologies Ltd. (NASDAQ: IINN)
undefined
Inspira™ Technologies Signs Strategic OEM Agreement with Terumo Cardiovascular
undefined
Inspira™ Technologies Interview to Air on Bloomberg U.S. on the RedChip Money Report®
#Partners
Inspira(TM) Technologies Interview to Air on Bloomberg U.S. on the RedChip Money Report(R)
undefined
Inspira™ Technologies Begins Manufacturing of the ALICE™ CPB Device, ahead of planned 2023 FDA submission
undefined
Inspira™ Technologies Signs Agreement to Conduct Clinical Study of HYLA™ Blood Sensor
#Partners
Inspira™ Technologies Reports Third Quarter 2022 Financial Results
#Investment #Partners
Inspira™ Technologies Signs a Strategic Agreement in Europe to potentially provide $26.1 for Deployment of 1,364 HYLA™ Blood Sensors
#Partners
Inspira™ Technologies Granted Patent by the Israeli Patent Office for Key Safety Component for the INSPIRA™ ART System
undefined
Inspira™ Technologies Reveals Next Generation Liby™ System, an Extracorporeal Membrane Oxygenation System, Targeting a $531 Million Global ECMO Market
#Investment
Inspira™ Technologies Develops a Non-Invasive Blood Sensor Designed to Alert Real-Time Change in Patients - Potentially Targets $2.5 Billion ABG Market
#Customers
Inspira Technologies Has Listed an FDA Class I 510(k) Exempt component of the ART system
#Customers
Inspira™ Technologies Reveals Next Generation Liby™ System, an Extracorporeal Membrane Oxygenation System, Targeting a $531 Million Global ECMO Market
#Investment #Customers
Inspira Technologies Announces Deployment Agreement in the Israeli Market to Target $15M
#Partners
Inspira Technologies Signs a Strategic Agreement in the U.S. to Target $212 Million for Inspira Over a 7-Year Period, Subject to Regulatory Approvals
#Partners
Inspira Technologies' "Artificial Lung" to Acquire a Digital Edge: The Company Contracted GlobalLogic, a Hitachi Group Company, for advanced digital product engineering services
#Partners
Inspira Technologies Reached Important Milestone as It Completed a Pump Bench Study
#Investment #Expand
Inspira Technologies and Ben-Gurion University Have Developed a Platform Designed to Prevent Blood Clotting in Inspira's ART System
#Partners #Investment
Inspira Technologies OXY B.H.N. Ltd Announces Closing of Initial Public Offering
#Public Trading
Inspira Technologies OXY B.H.N. Ltd Announces Pricing of Initial Public Offering
#Public Trading
Q&A: An intelligent oxygenation system that could eliminate need for ventilators
#Customers
הקורונה מטיסה את שאיפות ההנפקה של אינספירה
#Investment #Public Trading #Partners
Inspira Technologies Files U.S. Patent Application for its Innovative Respiratory Support Technology;Engages Leading U.S. Investment Bank for NASDAQ Listing
#Customers #Expand